Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast for prevention of nasal polyp recurrence
IRCT20190618043934N16Phase 3Completed
- Sponsor
- Vice Chancellor for Research, Birjand University of Medical Sciences
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of montelukast in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by Vice Chancellor for Research, Birjand University of Medical Sciences. Started Jan 2023; status: completed.
02
Drugs
montelukast
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on IRCT20190618043934N16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190618043934N16.